United States Biologics and Biosimilars Market Report 2016

United States Biologics and Biosimilars Market Report 2016

1 Biologics and Biosimilars Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Classification of Biologics and Biosimilars

1.2.1 Biologics

1.2.2 Biosimilars

1.2.3 Type III

1.3 Application of Biologics and Biosimilars

1.3.1 Tumor

1.3.2 Diabetes

1.3.3 Cardiovascular

1.3.4 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biologics and Biosimilars (2011-2021)

1.4.1 United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)

1.4.2 United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

2 United States Biologics and Biosimilars Competition by Manufacturers

2.1 United States Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Biologics and Biosimilars Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Biologics and Biosimilars Average Price by Manufactures (2015 and 2016)

2.4 Biologics and Biosimilars Market Competitive Situation and Trends

2.4.1 Biologics and Biosimilars Market Concentration Rate

2.4.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Biologics and Biosimilars Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Biologics and Biosimilars Sales and Market Share by Type (2011-2016)

3.2 United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

3.3 United States Biologics and Biosimilars Price by Type (2011-2016)

3.4 United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)

4 United States Biologics and Biosimilars Sales (Volume) by Application (2011-2016)

4.1 United States Biologics and Biosimilars Sales and Market Share by Application (2011-2016)

4.2 United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Biologics and Biosimilars Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Biologics and Biosimilars Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Roche

5.2.2 Biologics and Biosimilars Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Amgen

5.3.2 Biologics and Biosimilars Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 AbbVie

5.4.2 Biologics and Biosimilars Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi

5.5.2 Biologics and Biosimilars Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Johnson & Johnson

5.6.2 Biologics and Biosimilars Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Novo Nordisk

5.7.2 Biologics and Biosimilars Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Novartis

5.8.2 Biologics and Biosimilars Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

6 Biologics and Biosimilars Manufacturing Cost Analysis

6.1 Biologics and Biosimilars Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Biologics and Biosimilars

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Biologics and Biosimilars Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Biologics and Biosimilars Market Forecast (2016-2021)

10.1 United States Biologics and Biosimilars Sales, Revenue Forecast (2016-2021)

10.2 United States Biologics and Biosimilars Sales Forecast by Type (2016-2021)

10.3 United States Biologics and Biosimilars Sales Forecast by Application (2016-2021)

10.4 Biologics and Biosimilars Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Biologics and Biosimilars

Table Classification of Biologics and Biosimilars

Figure United States Sales Market Share of Biologics and Biosimilars by Type in 2015

Figure Biologics Picture

Figure Biosimilars Picture

Table Application of Biologics and Biosimilars

Figure United States Sales Market Share of Biologics and Biosimilars by Application in 2015

Figure Tumor Examples

Figure Diabetes Examples

Figure Cardiovascular Examples

Figure Others Examples

Figure United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)

Figure United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Table United States Biologics and Biosimilars Sales of Key Manufacturers (2015 and 2016)

Table United States Biologics and Biosimilars Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers

Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers

Table United States Biologics and Biosimilars Revenue by Manufacturers (2015 and 2016)

Table United States Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Biologics and Biosimilars Revenue Share by Manufacturers

Table 2016 United States Biologics and Biosimilars Revenue Share by Manufacturers

Table United States Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015

Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers

Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers

Table United States Biologics and Biosimilars Sales by Type (2011-2016)

Table United States Biologics and Biosimilars Sales Share by Type (2011-2016)

Figure United States Biologics and Biosimilars Sales Market Share by Type in 2015

Table United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

Table United States Biologics and Biosimilars Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)

Table United States Biologics and Biosimilars Price by Type (2011-2016)

Figure United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)

Table United States Biologics and Biosimilars Sales by Application (2011-2016)

Table United States Biologics and Biosimilars Sales Market Share by Application (2011-2016)

Figure United States Biologics and Biosimilars Sales Market Share by Application in 2015

Table United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)

Figure United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Biologics and Biosimilars Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Biologics and Biosimilars Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Biologics and Biosimilars Sales Market Share (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie Biologics and Biosimilars Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Biologics and Biosimilars Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Biologics and Biosimilars Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Biologics and Biosimilars Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Biologics and Biosimilars Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure United States Biologics and Biosimilars Production and Growth Rate Forecast (2016-2021)

Figure United States Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Table United States Biologics and Biosimilars Production Forecast by Type (2016-2021)

Table United States Biologics and Biosimilars Consumption Forecast by Application (2016-2021)